Homepage
Upcoming Webinar: Strategies to Accelerate Preclinical Development of Antibody-Drug Conjugates
Learn about essential strategies and methodologies for evaluating ADC efficacy, resistance, and immunogenicity that address both antibody-specific and payload-specific mechanisms
White Paper: Streamlining Gene Therapy with AAVs
In our latest white paper, critical considerations for a successful AAV discovery and development pipeline are discussed.
On-Demand Webinar: Strategies for Screening and Characterizing Targeted Covalent Inhibitors
Learn about innovative approaches to screen for covalent binders, strategies for the synthesis of covalent warheads, and assays to optimize the drug-like properties of these molecules
Poster: Targeted Protein Degradation Platform
Learn about the capabilities of our targeted protein degradation platform and TPD research strategies through relevant case studies
WuXi Biology
A full spectrum of biology services and solutions, supporting stand-alone and integrated projects, from target discovery to candidate selection and into the clinic
Enabling Unbounded Possibilities
WuXi Biology provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to candidate selection and into the clinic. Our world-class discovery platform is backed by nearly 3000 scientists, offering expertise in all major disease areas and target classes, across all therapeutic modalities. From small molecules, oligonucleotides, and peptides to antibodies, cell, and gene therapies, our state-of-the-art services, fast turnaround times, and quick study launches meet the diverse needs of our clients.
Speak with a SpecialistTarget Discovery to Candidate Selection and Beyond
Supporting stand-alone and integrated projects
Comprehensive platform from target ID to drug candidates
Target Identification and Validation
Finding druggable targets
Comprehensive coverage of target classes and therapeutic modalities
Hit Identification
Screening services to accelerate drug discovery
Integrated platform with diverse methods to identify hit compounds
Hit Validation and Early Optimization
Confirming chemistry tractability
In vitro screening platform to support medicinal chemistry
Lead Discovery Services
Enhancing the most promising compounds
In vivo services to accelerate drug discovery
Preclinical Drug Development
Enabling the selection of the best candidates
Integrated platform for preclinical R&D to accelerate timelines
Investigational New Drug Discovery
Comprehensive IND enabling testing platform
Supporting clients from research to market
Latest Science
Latest Poster
Production and Characterization of Protein Biologics
Production and Characterization of Protein Biologics
VIEW PosterLatest Publication
Discovery of GuaB Inhibitors for the Treatment of...
Small molecule GuaB inhibitors that are potent against MTB
VIEW PublicationLatest Publication
Small Molecule Reactivator of p53 Y220C Mutant
Small-Molecule Reactivator of p53 Y220C Mutant
VIEW PublicationLatest Presentation
BaF3 Models Carrying HER2 Mutations
BaF3 Models Carrying HER2 Mutations
VIEW PresentationLatest Poster
Imiquimod-induced Psoriasis-like Dermatitis in NHP
Imiquimod-induced Psoriasis-like Dermatitis in NHP
VIEW PosterLatest Poster
NLRP3 Inhibitor Reverses Melanoma-Induced Vitiligo
NLRP3 Inhibitor Reverses Melanoma-Induced Vitiligo
VIEW PosterLatest Poster
DELvision: A Protein-DEL Interaction Database
DELvision: A Protein-DEL Interaction Database
VIEW PosterLatest Poster
Targeted Protein Degradation Platform
Targeted Protein Degradation Platform
VIEW PosterLatest White Paper
Streamlining Gene Therapy with AAVs
Streamlining Gene Therapy with AAVs
VIEW White PaperLatest Poster
Developing Novel AR Mutant Prostate Cancer Models
Developing Novel AR Mutant Prostate Cancer Models
VIEW Poster